Ethnic uses, pharmacological and phytochemical profile of genus Grewia
-
Upload
independent -
Category
Documents
-
view
1 -
download
0
Transcript of Ethnic uses, pharmacological and phytochemical profile of genus Grewia
This article was downloaded by: [University of Peshawar]On: 25 May 2014, At: 20:18Publisher: Taylor & FrancisInforma Ltd Registered in England and Wales Registered Number: 1072954 Registeredoffice: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Journal of Asian Natural ProductsResearchPublication details, including instructions for authors andsubscription information:http://www.tandfonline.com/loi/ganp20
Ethnic uses, pharmacological andphytochemical profile of genus GrewiaWali Ullah a , Ghias Uddin a & Bina Shaheen Siddiqui ba Institute of Chemical Sciences, University of Peshawar ,Peshawar , 25120 , Pakistanb International Center for Chemical Sciences, HEJ ResearchInstitute of Chemistry, University of Karachi , Karachi , 75270 ,PakistanPublished online: 01 Feb 2012.
To cite this article: Wali Ullah , Ghias Uddin & Bina Shaheen Siddiqui (2012) Ethnic uses,pharmacological and phytochemical profile of genus Grewia , Journal of Asian Natural ProductsResearch, 14:2, 186-195, DOI: 10.1080/10286020.2011.639764
To link to this article: http://dx.doi.org/10.1080/10286020.2011.639764
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the“Content”) contained in the publications on our platform. However, Taylor & Francis,our agents, and our licensors make no representations or warranties whatsoever as tothe accuracy, completeness, or suitability for any purpose of the Content. Any opinionsand views expressed in this publication are the opinions and views of the authors,and are not the views of or endorsed by Taylor & Francis. The accuracy of the Contentshould not be relied upon and should be independently verified with primary sourcesof information. Taylor and Francis shall not be liable for any losses, actions, claims,proceedings, demands, costs, expenses, damages, and other liabilities whatsoever orhowsoever caused arising directly or indirectly in connection with, in relation to or arisingout of the use of the Content.
This article may be used for research, teaching, and private study purposes. Anysubstantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,systematic supply, or distribution in any form to anyone is expressly forbidden. Terms &Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions
Ethnic uses, pharmacological and phytochemical profile of genusGrewia
Wali Ullaha*, Ghias Uddina and Bina Shaheen Siddiquib
aInstitute of Chemical Sciences, University of Peshawar, Peshawar 25120, Pakistan; bInternationalCenter for Chemical Sciences, HEJ Research Institute of Chemistry, University of Karachi, Karachi
75270, Pakistan
(Received 23 May 2011; final version received 20 October 2011)
A number of species of genus Grewia have been used as medicinal agents to treatseveral diseases. This review based on 45 literary sources discusses the currentknowledge of traditional uses, chemistry, biological effects, and toxicity of differentspecies of this genus. Triterpenoids, steroids, glycosides, flavones, lignans, phenolics,alkaloids, lactones, anthocyanins, flavones, and organic acids have been isolated fromvarious species of this genus. The extracts and preparations from the various plants,which are expectantly safe, exhibited various biological effects, e.g. anti-oxidant, anti-bacterial, hepatoprotective, anti-inflammatory, anti-emetic, anti-malarial, analgesic,and anti-pyretic activities.
Keywords: Grewia; pharmacological; toxicological characteristics
1. Introduction
Grewia genus (family: Tiliaceae) com-
prises approximately 150 species, small
trees or shrubs, distributed in subtropical
and tropical regions, including tropical
Africa, Arabia, Madagascar, the Himalaya,
India, Pakistan, China, Bangladesh, Myan-
mar, Thailand, Malaysia, the pacific
islands, and northern Australia. In Pakistan,
10 species of genus Grewia are identified.
They are Grewia micrcos, G. optiva, G.
tenax, G. helicterifolia, G. glabra, G.
damine, G. villosa, G. sapida, G. asiatica,
and G. elastic [1,2]. Linnaeus identified
two species of genus Grewia: G. acciden-
talis from tropical and G. orientalis from
Sri Lanka and named after Nehemiah Grew
(1641–1712), one of the founders of plant
physiology [3]. During the last few
decades, medicinal properties of many
species have been identified [4]. The
barks and roots of G. tiliaefolia are used
to treat skin diseases, hypertension, ulcers,
diarrhea, inflammatory bowel diseases,
pruritis, jaundice, burning sensation, thirst,
throat complaints, biliousness, dysentery,
infectious diseases, and diseases of the nose
and of the blood [5–7]. Traditional medical
practitioners residing in the vicinity of
the forests of the Thirtharameshwara range
and Ubbrani range of Western Ghats of
Karnataka, India, were using the stem bark
extracts and pastes for curing jaundice,
hepatic disorders, and bronchial and
urinary infections [8]. G. asiatica was
initially cultivated mainly for its sour fruits
until its high medicinal value was dis-
covered. The fruits and barks of this plant
are used for the treatment of diarrhea, blood
disorders and for reducing fever [9]. G.
bicolor is a part of Sudanese traditional
medicine and is used in the treatment of
ISSN 1028-6020 print/ISSN 1477-2213 online
q 2012 Taylor & Francis
http://dx.doi.org/10.1080/10286020.2011.639764
http://www.tandfonline.com
*Corresponding author. Email: [email protected]
Journal of Asian Natural Products Research
Vol. 14, No. 2, February 2012, 186–195
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
skin lesions and sometimes also used as a
tranquilizer [9]. An extract of G. villosa is
used in the treatment of tuberculosis [10].
G. microcos is reported to be used for the
treatment of indigestion, eczema and itch,
typhoid fever, dysentery, and syphilitic
ulceration of mouth [11].G. tenax is a plant
that has been used in popular medicines in
various ways in different countries for cure
of jaundice, pulmonary infections, and
asthma. Leaves are used to treat trachoma.
Decoction and fruit juice are used for their
tonic and anti-anemic properties [6]. G.
tiliafolia is a tree found in India, Sri Lanka,
tropical Africa, Burma, and Nepal. Its bark
is used in ayurvedic medicine to treat
vitiated conditions of Pitta and Kapha,
burning sensation, cough, skin diseases,
wounds, ulcers, diarrhea, seminal weak-
ness, general debility, and hypertension
[4,5,12,13]. The mucilage and the hot water
extract of the bark are used as an antidote
for opium poisoning in human adults [14].
2. Pharmacology
2.1 Anti-malarial activity
The crude extract from G. bilamellata
showed anti-malarial activity (IC50 ¼ 2.2
and 1.7mg/ml). Bioassay-directed frac-
tionation of the methanolic extract
prepared from a sample of the combined
O
1 3 4
76
H H
HO
HO
H
HOH
HO
H
HO
HO
HO
OH
O
Figure 1. Triterpenes from different species of Grewia genus.
N
HN
NHN
H3CO
10 11 12
NHN
HO
Figure 2. Alkaloids from different species of Grewia genus.
Journal of Asian Natural Products Research 187
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
leaves, twigs, and stems of G. bilamellata
led to the isolation of eight lignans
including two coumarinolignan, four neo-
lignans, two Haworth lignans, two triter-
penes, one quinol derivative, and one
sterol glucoside. Bioassay results indicated
that the isolates 3a,20-lupandiol, grewin,
nitidanin, 2a,3b-dihydroxy-olean-12-en-
28-oic acid, and 2,6-dimethoxy-1-aceto-
nylquinol possessed in vitro anti-malarial
activity against Plasmodium falciparum
(IC50 ¼ 19.81 M) [15].
2.2 Anti-microbial activity
G. bicolor is a part of Sudanese traditional
medicine, and is used in the treatment of
skin lesions and also sometimes as a
tranquilizer [9]. Alkaloids, harman, 6-
methoxyharman, and 6-hydroxyharman,
isolated from the methanol extract of this
plant, showed anti-bacterial properties
[16]. Fruits of G. asiatica and G. tiliafolia
possess anti-microbial activities [17,18].
Van Vuuren (2008) determined anti-
bacterial activity of G. occidentalis [19].
Crude methanolic extract from G. asiatica
was fractionated into three major fractions,
viz. phenolic acids, flavonols and antho-
cyanins, and analyzed for their total
phenolic, flavonoid contents, and anti-
microbial effects. All fractions showed a
significant anti-bacterial activity except
anthocyanin. Being the most active,
phenolic acid fractions were also tested
for their anti-fungal activity, which sub-
stantially inhibited all the tested fungal
strains [20]. Mudassir et al. found that the
methanolic extract of G. erythraea showed
a significant anti-fungal and anti-bacterial
activities [21].
2.3 Anti-emetic activity
A 70% aqueous methanolic extract of G.
lasiodiscus root was fractionated on
column chromatography using solvents
of increasing polarities to yield three
O
O
OHOH
HO
HO
HO
OH O
15 16
17
OHOHO
OH O
OH
OH
HO
HO
HO
O
O
HOOH
OH
OH
O+HO
OH
OH
OHCl–
Figure 3. Flavones and anthocyanin from Grewia species.
W. Ullah et al.188
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
OO
O
19 20
21
23
22
HO
HO
OCH3
HOO O
OH3CO
HO
OCH3
HO
OH
OCH3
HOO
H
H
OH
H
H
OH
OCH3
OH
OCH3
HO
H
OH
OH
H
H
OH
O
OH
O
O
OH3CO
HO
OCH3
HO
O
H
H
H
OCH3
Figure 4. Coumarinolignans and neolignans from Grewia species.
OO
OH
24
27 32
26 28
HO
OHHO
O O
OHHO
OH
HO
O
OH
HO HHO
OH
O
OH
O
O
O
O
Figure 5. Structures of other compounds.
Journal of Asian Natural Products Research 189
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
Table 1. Different classes of compounds isolated from Genus Grewia.
S. No. Compounds Species Ref.
Triterpenes1 Friedelin G. tiliaefolia, G. biloba [36]2 Epi-friedelan-3-ol G. biloba [36]3 Ursene-3,19,28-triol G. villosa [38]4 a-Amyrin G. villosa [38]5 Ursolic acid G. villosa [38]6 3a,20-Lupandiol G. bilamellata [15]7 2a,3b-dihydroxyolean-
12-en-28-oic acidG. bilamellata [15]
8 Lupeol G. bicolour, G. tiliaefolia,G. damine
[14,16]
9 Betulin G. bicolour, G. tiliaefolia,G. damine
[14,16]
Alkaloids10 Harman G. bicolour [16]11 6-Methoxyharman G. bicolour [16]12 6-Hydroxyharman G. bicolour [16]
Sterols13 b-Sitosterol G. bicolour, G. biloba [16,37]14 Daucosterol G. bilamellata [15]
Flavones15 Vitexin G. damine [39]16 Isovitexin G. damine [39]
Anthocyanin17 Cyanidin 3-galactoside G. asiatica [40]
Coumarinolignans18 Grewin G. bilamellata [15]19 Nitidanin G. bilamellata [15]20 Cleomiscosin D G. bilamellata [15]
Neolignans21 8-O-40-Neolignanguaia-
cylglycerol-b-coniferylether(threo)
G. bilamellata [15]
22 8-O-40-Neolignanguaia-cylglycerol-b-coniferylether (erythro)
G. bilamellata [15]
23 Bilagrewin G. bilamellata [15]Other compounds24 Gulconic acid g-lactone G. tiliafolia [23]25 3,21,24-trimethyl-5,7-
dihydroxyhentriaconta-noic acid d-lactone
G. asiatica [23]
26 D-erythro-2-hexenoicacid g-lactone
G. tiliafolia [23]
27 Vitamin A G. asiatica [9]28 Vitamin C G. asiatica [9]29 Heneicosanoic acid G. biloba [37]30 Propyl palmitate G. biloba [37]31 Grewinol G. asiatica [41]32 2,6-Dimethoxy-1-aceto-
nylquinolG. bilamellata [15]
W. Ullah et al.190
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
fractions. The effect of the extract on
pentobarbitone-induced hypnosis was eval-
uated in mice, while the anti-emetic
activities of the extract and its fractions
were studied on anhydrous copper sulfate-
induced emesis in 1-day-old chickens.
The oral median lethal dose (LD50) of
extract was studied and estimated to be
774 mg/kg [22].
2.4 Hepatoprotective/radioprotectiveactivity
Bioassay-directed fractionation and chro-
matography of the methanolic extract from
the stem bark of G. tiliafolia have resulted
in the isolation of g-lactones, having
hepatoprotective activities [23]. The radio-
protective effect of G. asiatica fruit that
contains anthocyanin-type cyanidin 3-
galactoside, vitamins C and A, minerals,
carotenes and dietary fibers was studied.
Earlier research showed that supplemen-
tation of G. asiatica fruit extract can
improve radiation-induced depletion in
protein level and can inhibit the radi-
ation-induced lipid peroxidation in brain
[24], cerebrum [25,26], liver [27,28], and
blood [29]. A study has been performed on
assessing the histological evidence of
radioprotective efficacy of G. asiatica
fruit in liver along with its efficacy to
protect DNA and RNA damage in the liver
of Swiss albino mice [30].
2.5 Anti-oxidant activity
Methanolic crude extract of G. tiliaefolia
was checked against different radical
systems comprising superoxide radical
(O22), hydroxyl radical (OH), and nitric
oxide radical (NO) and showed potential
anti-oxidant activity in the in vitro model
system [31]. Sharma and Sisodia (2009)
found that G. asiatica fruit extract has
strong radical scavenging activity in
2,2-diphenyl-1-picrylhydrazyl (DPPH)
and O22 assays [32]. Solvent extracted
fractions of G. asiatica leaves were
screened for in vitro anti-oxidant properties
using standard procedures. The solvent
extracted fractions such as petroleum
ether, benzene, ethyl acetate, methanol,
water, and 50% crude methanolic extracts
exhibited IC50 values of 249.60 ^ 7.37,
16.19 ^ 2.132, 26.17 ^ 1.49, 27.38 ^
1.80, 176.14 ^ 5.53, and 56.40 ^
3.98mg/ml, respectively in DPPH and
22.12 ^ 02.65, 27.00 ^ 01.62, 47.38 ^
05.88, 56.85 ^ 06.16, 152.75 ^ 5.76, and
72.75 ^ 13.76 mg/ml, respectively, in
nitric oxide radical inhibition assays.
These values are comparable with stan-
dards such as ascorbic acid and quercetin.
G. asiatica leaves showed an anti-oxidant
activity [33].
2.6 Anti-proliferative activity
Study on G. tiliafolia proved that the
methanolic extract has a potential tumor
cell suppression activity in the selected
in vitro cell culture system [31].
2.7 Analgesic and anti-pyretic activity
Analgesic and anti-pyretic activities of the
aqueous extract of G. tiliaefolia Vahl
leaves were detected using morphine and
paracetamol at the dose of 10 and
150 mg/kg i.p. as standard drugs. The effect
observed was comparable to that of
paracetamol [34].
2.8 Anti-inflammatory activity
The fruits of G. asiatica are used as an
astringent and as an anti-inflammatory
agent [9].
3. Nutritional value
The ripe fruits of G. optiva are edible and
the raw or cooked fruits have a pleasant
acid taste. The leaves are rated as good
fodder and the trees are heavily lopped for
this purpose in the winter months when
usually no other green fodder is available.
The green leaves constitute about 70% of
Journal of Asian Natural Products Research 191
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
the total green weight of the branches.
Leaf fodder yield is reported to be
9.98 £ 103 kg/ha from 2-year-old plants,
and green fodder yield from mature trees is
reported to be 12–30 kg. Leaves are fairly
rich in protein and other nutrients and do
not contain tannins. Crude protein is
highest in young leaves, and in winter
leaves, but decreases during the rainy
season [3]. G. coriacea, found in tropical
forests of central Africa, has edible
fruits, which is used for producing
species. It is one of the most important
commercial spontaneous fruit crops in the
republic of Congo (Brazzaville). However,
similar to many other spontaneous fruits of
the tropical rain forest in Africa, G.
coriacea remains poorly studied and its
nutritional potential is unknown. With the
aim of valorization of the tropical
vegetable resources, and also the diversi-
fication of the lipid resources for edible
purposes and for cosmetic industry,
evolution of the lipid contents and their
composition in the kernels of this fruit
starting from the fruit setting until its
maturation was studied. Lipid composition
was determined by soxhlet and by gas
chromatography. The study showed that
kernel oils were three times more richer
in unsaturated fatty acids than saturated.
The presence of the arachidic, stearic,
and palmitic acids gives these oils the
potentialities for human nutrition or
cosmetics [35].
4. Chemical constituents
To the best of our knowledge, the first
phytochemical investigation on Grewia
genus can be traced back to 1965.
Friedelin was the first pentacyclic triterp-
noid reported from G. tiliaefolia [36], and
its presence in G. biloba was also
confirmed [37]. Since then, plenty of
studies regarding chemical and biological
aspects of plants within the genus Grewia
have been reported. So far, 32 compounds
have been identified, some of which are of
significant biological importance (Figures
1–5, Table 1).
4.1 Triterpenoids
Friedelin was the first pentacyclic triter-
penoid reported from G. tiliaefolia [36]. It
was also reported from G. biloba along
with epi-friedelan-3-ol [37]. Ursene-
3,19,28-triol, a-amyrin, and ursolic acid
were isolated from the roots of G. Villosa
[38]. Anti-malarial bioassay-directed frac-
tionation of the methanolic extract pre-
pared from a sample of the combined
leaves, twigs, and stems of G. bilamellata
led to the isolation of compounds, includ-
ing two triterpenes 3a,20-lupandiol and
2a,3b-dihydroxy-olean-12-en-28-oic acid
[15]. Lupeol and betulin were reported
from G. bicolour, G. tiliaefolia, and
G. damine [14,16].
4.2 Alkaloids
Grewia genus is famous for alkaloids.
Three alkaloids, harman, 6-methoxyhar-
man, and 6-hydroxyharman, isolated from
the methanolic extract of this plant have
anti-bacterial properties [16].
4.3 Sterols
Two sterols including b-sitosterol and
daucosterol are reported from different
species of this genus [15,16,37].
4.4 Flavones
Two flavone C-glycosides, vitexin and
isovitexin, have been isolated from n-
butanol fraction of the methanolic extract
of leaves of G. damine [39].
4.5 Anthocyanins
Only one anthocyanin, cyanidin, 3-galac-
toside, has been reported from the fruits of
G. asiatica [40].
W. Ullah et al.192
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
4.6 Lignans
Lignans isolated from the plants of the
genus Grewia covered coumarinolignans
and neolignans being the major
components.
4.6.1 Coumarinolignans
Three coumarinolignans grewin, nitidanin,
and cleomiscosin D were isolated from
G. bilamellata [15].
4.6.2 Neolignans
Three neolignans have been reported from
genus G. bilamellata. They were isolated
and characterized from chloroform fraction
of G. bilamellata as 8-O-40 neolignans,
guaiacylglycerol-b-coniferyl ether isomers
(threo and erythro) and bilagrewin [15].
4.7 Lactones
Three lactones, gulonic acid g-lactone,
3,21,24-trimethyl-5,7-dihydroxyhentria-
contanoic acid d-lactone, and D-erythro-2-
hexenoic acid, g-lactone are reported from
G. tiliaefolia and G. asiatica [23].
4.8 Vitamins
The presence of vitamins A and C has also
been reported from G. asiatica [9].
4.9 Organic acids
Heneicosanoic acid, an organic acid, was
reported from G. biloba [37].
4.10 Others
Propyl palmitate, 2,6-dimethoxy-1-aceto-
nylquinol, and grewinol are reported from
G. biloba, G. bilamellata, and G. asiatica,
respectively [15,37,41].
5. Toxicology
Phytochemical and histopathological
studies were carried out by Onwuliri et al.
(2006) on the leaves and stem bark extracts
of G. mollis and the result revealed the
presence of tannins, saponins, flavonoids,
glycosides, phenols, terpenes, steroids, and
the absence of alkaloids in G. mollis bark,
while toxicological result showed that the
plant is safe for human consumption [42].
G. mollis stem bark used locally in Nigeria
as a food additive was mixed with the
normal diet at 0%, 1%, 5%, and 10% and
fed to male Wister rats over a 4-week
period. No deaths or remarkable changes
in general appearance or behavior were
observed in the animals treated. Signifi-
cant ( p , 0.05) increases in serum trans-
aminase activities, accompanied by
decreased food intake, were observed in
rats that were fed with the stem bark at
10% dietary level. Treatments had no
effect on serum alkaline phosphatase
activity, urea, creatinine, triglycerides,
cholesterol, glucose concentrations and,
body and organ weights were determined.
These studies proved that at high concen-
trations, G. mollis stem bark may cause
liver injury [43].
6. Conclusion
Since some species of genus Grewia have
been used as folk medicines for a long time
in Asian countries, pharmacological inves-
tigations have revealed that the extracts of
this genus are highly bioactive. The
knowledge of the extent and mode of
inhibition of specific compounds, which
are present in the plant extracts, may
contribute to the successful application of
such natural compounds for treatment of
infection disorder like fungal and bacterial
diseases. The present status of medicinal
plants and their products provide an
opportunity for the developing countries
to benefit from the emerging marks, as the
developing countries possess the most
biodiversity of medicinal plants. It is
concluded that in coordination with the
chemical literature finding resistant strains
of plant organism, biodiversity may lead to
Journal of Asian Natural Products Research 193
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
an unexpected research findings [44]. The
present findings will facilitate the research-
ers as a basic data for future research in
exploiting the hidden potential of this
important genus which has not been
explored so far.
References
[1] S.I. Ali, Flora of West Pakistan, FamilyTiliaceae (Fakhri Printing Press, Karachi,1974), pp. 1–3.
[2] C. Bayer and K. Kubitzki, Malvaceae, TheFamilies and Genera of Vascular Plants,Flowering plants, Dicoyledons (Springer-Verlag, Berlin, 2003), pp. 225–311.
[3] C. Orwa, A. Mutua, R. Kindt,R. Jamnadass, and A. Simons, Agrofor-estree Database: A Tree Reference andSelection Guide Version 4.0 (2009),pp. 1 –5 (http://www.worldagrofores-try.org/af/treedb/).
[4] L.V. Asolkar, K.K. Kakkar, O.J. Chakre,R.N. Chopra, S.L. Nayar, and I.C. Chopra,Glossary of Indian Medicinal Plants(Publications & Information Directorate,New Delhi, 1992), p. 362.
[5] S. Raghunathaiyar, Indian MedicinalPlants (Orient Longman, Hyderabad,1996), Vol. 3, pp. 104–105.
[6] B.N. Bowden, in Tiliaceae, FloweringPlants of the World, edited by B. Dod,(Oxford University Press, London, 1978),pp. 90–91.
[7] A.R. Juvekar, S.S. Sakat, A.S. Shah, andA.S. Wakade, Planta Med. 73, 825(2007).
[8] K.R. Kirthikar and B.D. Basu, Grewiatiliaefolia Vahl. Indian Medicinal Plants(Lalit Mohan Basu, Allahabad, 1975),pp. 1636–1638.
[9] A.K Yadav, Prospectives on New Cropsand New Uses (ASHS press, Alexandria,VA, 1999), pp. 348–352.
[10] A.K. Bashir, M.F. Ross, and T.D. Turner,Fitoterapia 58, 141 (1987).
[11] K.I. Kirtikar and B.D. Basu, IndianMedicinal Plants, 2nd ed. (Lalit MohanBasu, Allahabad, 1935), p. 394.
[12] Anon, The Wealth of India (Council ofScientific and Industrial Research, CSIR,New Delhi, 1987), pp. 264–266.
[13] J.F. Caius, J. Bombay Nat. Hist. Soc. 44,92 (1943).
[14] S. Badami, M.K. Gupta, S. Ramaswamy,S.R. Rai, M. Nanjaian, D.J. Bendell,R. Subban, and S. Bhojaraj, J. Sep. Sci.27, 129 (2004).
[15] C. Ma, H.J. Zhang, G.T. Tan, N.V. Hung,N.M. Cuong, D.D. Soejarto, and H.H.S.Fong, J. Nat. Prod. 69, 346 (2006).
[16] M.W.J.M. Jaspers, A.K. Bashir,J.H. Zwaving, and T.M. Malingre,J. Ethnopharm. 17, 205 (1986).
[17] M. Gupta, B.P. Shaw, and A. Mukherjee,Int. J. Ayurv. Res. 1, 106 (2010).
[18] Y.V. Ramshankar, P. Vinay, andP. Vijayan, Phcog. Mag. 4, 329 (2008).
[19] S.F. Van Vuuren, J. Ethnopharmacol.119, 462 (2008).
[20] R. Siddiqui, S. Naz, S. Ahmad, andS.A. Sayeed, Int. J. Food Sci. Tech. 46,250 (2011).
[21] M.A. Zaidi and S.A. Crow Jr, J. Ethno-pharmacol. 96, 331 (2005).
[22] A.Y. Tijani, S.E. Okhale, F.E. Oga, andS.Z. Tags, Afr. J. Biotech. 7, 3011(2008).
[23] M.B.K. Ahamed, V. Krishna, andC.J. Dandin, Eur. J. Pharmacol. 31, 42(2010).
[24] M. Ahaskar, K.V. Sharma, S. Singh, andR. Sisodia, Iran. J. Rad. Res. 5, 105(2007).
[25] R. Sisodia, M. Ahaskar, K.V. Sharma, andS. Singh, Acta Neurobiol. Exp. 68, 32(2008).
[26] M. Ahaskar, K.V. Sharma, S. Singh, andR. Sisodia, Pharmacologyonline 1, 344(2007).
[27] K.V. Sharma, A. Ahaskar, S. Singh, andR. Sisodia, Pharmacologyonline 1, 46(2007).
[28] R. Sisodia, S. Singh, K.V. Sharma, andM. Ahaskar, J. Environ. Pathol. Toxicol.Oncol. 27, 113 (2008).
[29] S. Singh, K.V. Sharma, M. Ahaskar, andR. Sisodia, J. Complement. Integr. Med. 5,14 (2008).
[30] K.V. Sharma and R. Sisodia, Iran. J. Rad.Res. 8, 75 (2010).
[31] N. Selvam, T.V. Vengatakrishnan,S. Murugesan, and S.D. Kumar, Int.J. Pharm. Life Sci. 1, 54 (2010).
[32] K.V. Sharma and R. Sisodia, J. Rad. Prot.29, 429 (2009).
[33] M.K. Gupta, R. Lagarkha, andD.K. Sharma, Asian J. Chem. 19, 3417(2007).
[34] S.S. Sakat and A.R. Juvekar, J. Pharm.Res. 2, 1475 (2009).
[35] Attibayeba, L. Ngantsoue, and D.Massamba, Riv. Ital. Sostanze Grasse87, 58 (2010).
[36] B. Anjaneyulu, V.B. Rao, A.K. Ganguly,T.R. Govindachari, B.S. Joshi, and
W. Ullah et al.194
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4
V.N. Kamat, Indian J. Chem. 3, 237(1965).
[37] B.K.M. Ahamed, V. Krishna, andK.H. Malleshappa, Planta Med. 75,478 (2009).
[38] A.K. Bashir, T.D. Turner, and M.S. Rose,Fitoterapia 53, 68 (1982).
[39] U.L.B. Jayasinghe, B.A.I.S. Balasooriya,A.G.D. Bandara, and Y. Fujimoto, Nat.Prod. Res. 18, 499 (2004).
[40] M.G. Nair, D.L. Deueitt, H. Wang,D. Krempir, and W. Mody, Dietary foodsupplement containing natural cycloox-ygenase inhibitors and methods for
inhibiting pain and inflammation. USPatent Specification (2005).
[41] V. Lakshmi, S.K. Agarwal, andJ.S. Chauhan, Phytochemistry 15, 1397(1976).
[42] F.C. Onwuliri, J.D. Mawak, D.L. Wonang,and E.A. Onwuliri, Int. J. Nat. Appl. Sci.2, 225 (2006).
[43] W. Obidah, J.L. Godwin, Z. Joseph,J.Z. Fate, and M.A. Madusolumuo,J. Am. Sci. 6, 1544 (2010).
[44] S. Mahmud, H. Shareef, U.F. Arrukh,A. Kamil, and G.H. Rizwani, Pak. J. Bot.41, 1941 (2009).
Journal of Asian Natural Products Research 195
Dow
nloa
ded
by [
Uni
vers
ity o
f Pe
shaw
ar]
at 2
0:18
25
May
201
4